Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.810
+0.012 (1.49%)
At close: Mar 9, 2026, 4:00 PM EDT
0.794
-0.016 (-1.99%)
After-hours: Mar 9, 2026, 6:14 PM EDT

Cytosorbents Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
51505868182344
Upgrade
Market Cap Growth
-19.13%-14.14%-14.31%-62.87%-47.06%175.66%
Upgrade
Enterprise Value
70716858135272
Upgrade
Last Close Price
0.810.911.111.554.197.97
Upgrade
PS Ratio
1.381.401.861.954.228.39
Upgrade
PB Ratio
5.644.482.471.912.914.34
Upgrade
P/TBV Ratio
9.376.762.962.183.154.59
Upgrade
EV/Sales Ratio
1.911.992.181.693.126.64
Upgrade
Debt / Equity Ratio
3.012.420.780.520.220.01
Upgrade
Net Debt / Equity Ratio
2.172.130.18-0.11-0.61-0.89
Upgrade
Net Debt / EBITDA Ratio
-1.54-1.55-0.140.131.747.25
Upgrade
Net Debt / FCF Ratio
-1.96-1.60-0.190.112.1711.14
Upgrade
Asset Turnover
0.790.710.540.450.480.70
Upgrade
Inventory Turnover
2.983.432.673.392.974.62
Upgrade
Quick Ratio
1.481.081.442.864.147.54
Upgrade
Current Ratio
2.112.201.813.484.708.12
Upgrade
Return on Equity (ROE)
-93.26%-119.80%-99.38%-67.00%-34.64%-18.97%
Upgrade
Return on Assets (ROA)
-19.01%-20.91%-34.37%-25.27%-15.84%-11.05%
Upgrade
Return on Capital Employed (ROCE)
-39.90%-44.70%-82.10%-57.70%-30.00%-13.00%
Upgrade
Earnings Yield
-20.19%-41.64%-50.47%-48.51%-13.48%-2.28%
Upgrade
FCF Yield
-19.70%-29.57%-38.29%-50.74%-9.69%-1.84%
Upgrade
Buyback Yield / Dilution
-14.92%-21.90%-2.49%-0.49%-11.70%-20.35%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.